Independent neurotechnology intelligence

Cortex Signals

Clinical signal for the people building, backing, and interpreting brain-health technology.

Evidence-first analysisCommercial readinessClinical adoption lens

Coverage

What Cortex Signals covers

Selective analysis across clinically meaningful brain and behavior technologies, with attention to evidence, adoption, regulation, and commercial readiness.

Brain-computer interfacesNeuromodulationNeurogeneticsNeurodiagnosticsCognitive assessmentSensory and neurorehabilitation devicesDigital mental health treatment devicesClinically relevant neuro-adjacent AI

Audience

Who it is for

Neurotech investors assessing clinical and commercial signal

Founders and operators building regulated brain-health tools

Commercially minded clinicians tracking innovation beyond hype

Educators, analysts, and strategic teams needing sharper context

Published issues

Recent briefings built for judgment, not noise.

View issues

Consulting & briefings

Sharper context for neurotech decisions.

Cortex Signals offers custom market scans, clinical landscape briefings, founder research support, and strategic context for investors, operators, and clinical teams.

Request a conversation

Newsletter

Get the signal in your inbox.

Cortex Signals is a selective brief on neurotechnology, neurogenetics, brain-health devices, and the clinical adoption questions that matter.

Sheena M. Lee, DMSc, PA-C, founder of Cortex Signals

Founder

Sheena M. Lee, DMSc, PA-C

Sheena M. Lee is a clinician and educator with experience across psychiatry, neurology, intellectual and developmental disabilities, autism, and PA education. Cortex Signals reflects her interest in translating complex brain-health innovation into clinically informed, commercially useful intelligence.